Search Results - "LEBREC, D"

Non‐invasive evaluation of portal hypertension using shear‐wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis by Elkrief, L., Ronot, M., Andrade, F., Dioguardi Burgio, M., Issoufaly, T., Zappa, M., Roux, O., Bissonnette, J., Payancé, A., Lebrec, D., Francoz, C., Soubrane, O., Valla, D., Durand, F., Vilgrain, V., Castera, L., Rautou, P.‐E.

“…Summary Background Two algorithms based on sequential measurements of liver and spleen stiffness using two‐dimensional shearwave elastography (2D‐SWE) have…”
Get full text

Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients by Hillaire, S, Bonte, E, Denninger, M-H, Casadevall, N, Cadranel, J-F, Lebrec, D, Valla, D, Degott, C

“…Background: Non-cirrhotic portal hypertension of unknown cause is a poorly understood condition attributed to obstructive portal venopathy. Aim: To reassess…”
Get full text

Lack of clinical or haemodynamic rebound after abrupt interruption of beta‐blockers in patients with cirrhosis by Payancé, A., Bissonnette, J., Roux, O., Elkrief, L., Gault, N., Francoz, C., Nekachtali, O., Soubrane, O., Lebrec, D., Valla, D., Durand, F., Rautou, P.‐E.

“…Summary Background Beta‐blockers may have to be interrupted in patients with cirrhosis. The concept of a rebound after interruption of beta‐blockers is based…”
Get full text

Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats by Sztrymf, B, Rabiller, A, Nunes, H, Savale, L, Lebrec, D, Le Pape, A, de Montpreville, V, Mazmanian, M, Humbert, M, Herve, P

“…Inhibition of tumour necrosis factor-alpha (TNF-alpha), levels of which are increased in the blood of cirrhotic rats, prevents hyperdynamic circulatory state,…”
Get full text

Prevalence of Cardiomyopathy and Impact of the use of Non Selective Beta Blockers in End-Stage Liver Disease by Giannelli, V, Roux, O, Rautou, P.E, Wiess, E, Moreau, R, Lebrec, D, Francois, D, Francoz, C

Get full text

Pathological Analysis of the Liver of Patients with Cirrhosis and Hepatopulmonary Syndrome Reveals a Vascular Pattern of Damages by Lejealle, C, Paradis, V, Francoz, C, Soubrane, O, Lebrec, D, Valla, D, Durand, F, Rautou, P.E

Get full text

Plasma microvesicles levels can predict the development of hepatocellular carcinoma in patients with cirrhosis by Levi, C, Payancé, A, Bissonnette, J, Tanguy, M, Roux, O, Bouattour, M, Soubrane, O, Francoz, C, Lebrec, D, Vilgrain, V, Paradis, V, Valla, D, Durand, F, Boulanger, C.M, Rautou, P.-E

Get full text

Non-invasive evaluation of clinically significant portal hypertension: validation of two novel algorithms combining liver and spleen stiffness using shear-wave elastography in a large independent cohort of patients with cirrhosis by Elkrief, L, Rautou, P.-E, Ronot, M, Zappa, M, Burgio, M.Di, Roux, O, Bissonnette, J, Payancé, A, Lebrec, D, Francoz, C, Soubrane, O, Valla, D, Durand, F, Vilgrain, V, Castéra, L

Get full text

Pulmonary vascular disorders in portal hypertension by Herve, P, Lebrec, D, Brenot, F, Simonneau, G, Humbert, M, Sitbon, O, Duroux, P

“…The wide spectrum of pulmonary vascular disorders in liver disease and portal hypertension ranges from the hepatopulmonary syndrome characterized by…”
Get full text

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis by Deltenre, P., Mathurin, P., Dharancy, S., Moreau, R., Bulois, P., Henrion, J., Pruvot, F. R., Ernst, O., Paris, J. C., Lebrec, D.

“…: Transjugular intrahepatic portosystemic shunt (TIPS) is a more effective treatment for refractory ascites than large volume paracentesis (LVP), but the…”
Get full text

Hepatocyte microvesicle levels predict 6-month survival in patients with cirrhosis: results of a prospective study on 242 patients by Payancé, A, Silva-Junior, G, Bissonnette, J, Tanguy, M, Roux, O, Levi, C, Nekachtali, O, Baiges, A, Gea, V.H, Lebrec, D, Moreau, R, Valla, D, Durand, F, Boulanger, C.M, Garcia-Pagan, J.-C, Rautou, P.-E

Get full text

Review article: future indications for terlipressin therapy by Lebrec, D

“…Vasoconstrictor agents such as terlipressin (Glypressin) have been shown to have beneficial effects in the treatment of hepatorenal syndrome (HRS), in terms of…”
Get full text

Future indications for terlipressin therapy by Lebrec, D.

“…Summary Vasoconstrictor agents such as terlipressin (Glypressin®) have been shown to have beneficial effects in the treatment of hepatorenal syndrome (HRS), in…”
Get full text

A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis by Moreau, R, Elkrief, L, Bureau, C, Pérarnau, J.-M, Thévenot, T, Saliba, F, Louvet, A, Nahon, P, Oberti, F, Anty, R, Hillaire, S, Pasquet, B, Ozenne, V, Rudler, M, Ollivier-Hourmand, I, Robic, M.-A, D’Alteroche, L, Di Martino, V, Rautou, P.-E, Gault, N, Lebrec, D

Get full text

Relationship between the Fibrotest and portal hypertension in patients with liver disease by THABUT, D., IMBERT‐BISMUT, F., CAZALS‐HATEM, D., MESSOUS, D., MUNTENAU, M., VALLA, D. C., MOREAU, R., POYNARD, T., LEBREC, D.

“…Summary Background  The best technique to estimate portal hypertension (PHT) is to measure the hepatic venous pressure gradient (HVPG), which is an invasive…”
Get full text

Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: Analysis of the F7 liver-1288 study population by Thabut, D, D’Amico, G, Tan, P, De Franchis, R, Fabricius, S, Lebrec, D, Bosch, J, Bendtsen, F

“…Background & Aims The definition of failure to control bleeding agreed upon at the Baveno IV consensus meeting, included the Adjusted Blood Requirement Index…”
Get full text

Drug therapy for portal hypertension by Lebrec, D

“…[...]the choice of pharmacological treatment for portal hypertension is simple, and is based on the results of well established studies. [...]international…”
Get full text

666 ROLE OF HEPATIC CYCLIC AMP IN THE RENAL DYSFUNCTION ASSOCIATED TO THE DEVELOPMENT OF ASCITES IN PATIENTS WITH CIRRHOSIS by Ahloulay, M, Sogni, P, Moreau, R, Mallet, V, Pol, S, Lebrec, D

Get full text

608 GENE-EXPRESSION PROFILING REVEALS AN UNEXPECTED DEFECT IN INDUCTION OF INTERFERON TARGET GENES IN LPS-STIMULATED IMMUNE CELLS FROM CIRRHOTIC PATIENTS by Weiss, E, Fasseu, M, Rautou, P.-E, Elkrief, L, Paugam-Burtz, C, Valla, D, Lebrec, D, Moreau, R

Get full text

609 LPS INDUCES AN UNEXPECTED ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE (UPRER) IN IMMUNE CELLS FROM PATIENTS WITH CIRRHOSIS by Ouchia, L, Weiss, E, Fasseu, M, Elkrief, L, Rautou, P.-E, Hurtado-Nedelec, M, Valla, D, Lebrec, D, Moreau, R

Get full text